Q: With the offer on the table and the share price having moved so close to the asking price would you sell now? Also, could you please outline the details of the offer and the pros and cons. Thank you. John
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: BLU ... seems to have numerous broker buy recommendations but hardly moves ... your thoughts please
Q: There has not been a question regarding this company since early 2021. At that time it was trading around $5 and it was suggested the results would be binary. Now it is $15, could you provide an update on this company regarding its progress and growth in revenue/profitability. Thank you. John
Q: both companies keep hitting 52 week highs on large volume-so for me the old adage tends to apply-stocks that hit 52 week highs tend to go higher still, stocks that hit 52 week lows tend to go lower still.
i know both are speculative-what is your opinion, would you be a buyer.dave
i know both are speculative-what is your opinion, would you be a buyer.dave
Q: BLU ... your opinion on BLU ... risk, future growth, is this a buy ... thx much
Q: I know longer own GUD having sold it over a year ago due to dead money syndrome. However in the G&M today there was an excellent article today on some Canadian biotechs,eg Zyme, etc. that I encourage you to read.
As I've discussed in the past in this column there seemed to be a total vacuum of Biotechs in Canada, but having read this article my eyes are opened.
Are you guys looking into any of these opportunities?
https://www.theglobeandmail.com/business/article-biotech-blind-spot-how-canadas-big-investors-missed-the-boom/
Sheldon
As I've discussed in the past in this column there seemed to be a total vacuum of Biotechs in Canada, but having read this article my eyes are opened.
Are you guys looking into any of these opportunities?
https://www.theglobeandmail.com/business/article-biotech-blind-spot-how-canadas-big-investors-missed-the-boom/
Sheldon
Q: Hi 5i Team,
Any reason accounted for the 70% share price drop today? What is your view on this company?
Thank you for your professional advice.
Any reason accounted for the 70% share price drop today? What is your view on this company?
Thank you for your professional advice.
Q: No questions asked on Bellus for a few months. It seems to be doing quite well, hitting new highs and up substantially ytd. Just wondering if you have any information that would account for the performance.
Thank you
Neil
Thank you
Neil
Q: Hi 5i Team,
Your comment on Bellus Health’s earning and it’s future outlook please.
Thank you for your professional service and advice as always.
Your comment on Bellus Health’s earning and it’s future outlook please.
Thank you for your professional service and advice as always.
Q: Could you comment on the 60 million US public offering of common shares. Does this account for the sharp decline today of about 8%. Or is there more to it?
And is it a good sign for the stock that the company is looking to list on the Nasdaq.
Thanks - James.
And is it a good sign for the stock that the company is looking to list on the Nasdaq.
Thanks - James.
Q: Answer to shares jumping:
http://s1.q4cdn.com/543273785/files/doc_presentations/2019/06/BELLUS-Health-Corporate-Presentation-RJ-Life-Sciences-and-MedTech-Conference-June-19-2019-vFinal.pdf
Walter
http://s1.q4cdn.com/543273785/files/doc_presentations/2019/06/BELLUS-Health-Corporate-Presentation-RJ-Life-Sciences-and-MedTech-Conference-June-19-2019-vFinal.pdf
Walter
Q: Reason for BLU's spectacular share price jump today?
Thank you,
Walter
Thank you,
Walter
Q: Hi, unfortunately I'm holding the above and would like your take on the company if there is a chance they could make a comeback or should I take my loss and move on.
Thank you
Anthony
Thank you
Anthony
Q: In the healthcare sector, what are your views on Bellus Health (blu-t) which had a rapid progression lately and does not seem to be covered by analysts and on Resmed (rmd-n)? Which other companies could be a better alternative at the present time ?
Many thanks for your help,
Jacques
Many thanks for your help,
Jacques